Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/88880
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Long-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trial
Author: Meredith, I.
Worthley, S.
Whitbourn, R.
Walters, D.
McClean, D.
Ormiston, J.
Horrigan, M.
Wilkins, G.
Hendriks, R.
Matsis, P.
Muller, D.
Cutlip, D.
Citation: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2010; 5(6):692-697
Publisher: Baishideng
Issue Date: 2010
ISSN: 1969-6213
1774-024X
Statement of
Responsibility: 
Antonina A Mikocka-Walus
Abstract: AIMS: The 12-month results of RESOLUTE were favourable for the new Resolute stent. Two-year safety and efficacy results from RESOLUTE have been evaluated and are now reported. METHODS AND RESULTS: RESOLUTE was a prospective, multicentre, non-randomised, single-arm, controlled trial of the Resolute stent in 139 participants with symptomatic ischaemic heart disease due to single de novo lesions in a native coronary artery. The 2-year rates of MACE (all-cause death, myocardial infarction, emergent cardiac bypass surgery, and target lesion revascularisation [TLR]), death, late stent thrombosis, target vessel revascularisation (TVR), and target vessel failure (TVF) were assessed. Clinical events included two MACE (one TLR; one non-cardiac death) occurring between year one and two resulting in cumulative 2-year TLR, TVR, and TVF rates of 1.4%, 1.4%, and 7.9%, respectively. One possible stent thrombosis event occurred in the first year after stent implantation however no late or very late ARC-defined definite and probable stent thromboses occurred through two years. CONCLUSIONS: The 2-year data from RESOLUTE demonstrated no safety concerns including no late stent thrombosis or loss of effectiveness with the Resolute stent. The finding that few events occurred in year two is encouraging, yet requires verification in a larger population.
Keywords: Humans; Coronary Stenosis; Myocardial Infarction; Coronary Angiography; Treatment Outcome; Incidence; Survival Rate; Coated Materials, Biocompatible; Prospective Studies; Prosthesis Design; Myocardial Revascularization; Stents; Drug-Eluting Stents; Middle Aged; Time Factors; Australia; New Zealand; Female; Follow-Up Studies; Male; Graft Occlusion, Vascular
Rights: © 2010 Baishideng. All rights reserved.
RMID: 0030016769
DOI: 10.4244/EIJV5I6A114
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.